Seminal Clinical Trial in Healthy Adults Demonstrates Promising Preliminary Evidence of PlusCBD™ Oil in Sleep, Wellness, and Weight-loss applications

First-Ever Double-Blind, Randomized Study Titled, “Effects of a CBD-containing Supercritical Fluid Extract of Hemp on Markers of Optimal Wellness, Stress Resilience, and Recovery in Healthy Subjects,” Validates Benefits of Daily Supplementation with CV Sciences’ PlusCBD™ Oil products LAS VEGAS, June 17, 2019 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), … Continue reading Seminal Clinical Trial in Healthy Adults Demonstrates Promising Preliminary Evidence of PlusCBD™ Oil in Sleep, Wellness, and Weight-loss applications →

Continuing their commitment to excellence, the Company is proud to announce this landmark certification. LAS VEGAS, NV (January 4, 2019) — CV Sciences, Inc (OTCQB: CVSI) (the “Company”, “we” or “our”), a preeminent supplier and manufacturer of hemp CBD products through its industry-dominating brand  PlusCBD Oil™, is proud to announce its certification from the US … Continue reading CV Sciences, Inc. Named One of the First U.S. Hemp Authority™ Certified Manufacturers →

Forum to cover partnerships, industry keynotes and influential medical panels LAS VEGAS, Dec. 19, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB: CVSI) preeminent supplier and manufacturer of its industry dominating brand of finished products, PlusCBD Oil™, announced today that its Chief Executive Officer Joseph Dowling will be participating as a panelist at The 2nd Annual Neuroscience … Continue reading CV Sciences, Inc. Featured as a Panelist at 2nd Annual Neuroscience Innovation Forum in San Francisco →

Company’s industry-dominating hemp extract brand, PlusCBD Oil™ wins Best Retail/Brand Product category LAS VEGAS, Dec. 12, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our” or “we”), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including cannabidiol (CBD) oil and developer of specialty pharmaceutical therapeutics, announced today that it has received Nutritional Outlook’s 2018 Best of the … Continue reading CV Sciences, Inc. Receives Nutritional Outlook’s 2018 Best of the Industry Award →

As 2018 Farm Bill Momentum Rises, CV Sciences and Hemp Industries Association are ‘Charting The Course’ LAS VEGAS, Nov. 01, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB: CVSI) preeminent supplier and manufacturer of its industry dominating brand of finished products, PlusCBD Oil™, announced today that it will be a Title Sponsor of the 25thanniversary of HIACON Conference … Continue reading CV Sciences, Inc. to Sponsor 25th Anniversary HIACON Conference in Los Angeles, California on Nov 2-5, 2018 →

LAS VEGAS, Oct. 16, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc., (OCTQB: CVSI) preeminent supplier and manufacturer of industry leading hemp extract brand, PlusCBD Oil™, announces that the Company is now sponsoring Rodale Institute’s research on organic hemp farming alongside industry leaders Patagonia and Dr. Bronner’s. The Rodale Institute is the nation’s leading organic farming institution, dedicated to pioneering … Continue reading CV Sciences, Inc. Partners with the Rodale Institute on Organic and Industrial Hemp Research, Joining Patagonia and Dr. Bronner’s →

PlusCBD Oil™ Capsules featured as one of the industry-leading in efficacy and strength; Dr. Oz segment cites sales of CBD products expected to increase 700% over the next year LAS VEGAS, Oct. 09, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including industry … Continue reading CV Sciences, Inc.’s PlusCBD Oil™ featured on Oct. 3rd Episode of ‘The Dr. Oz Show’ →

LAS VEGAS, Sept. 25, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) preeminent supplier and manufacturer of hemp-derived phytocannabinoids including industry leading brand, PlusCBD Oil™ , announced today that it has introduced PlusCBD Oil™ Gummies at the Natural Product Expo East 2018. A new category of PlusCBD Oil™ products, PlusCBD Oil™ … Continue reading CV Sciences, Inc. Announces a New Category of Its Industry-Leading PlusCBD Oil™ Products, Hemp Extract Gummies →

First Hemp Extract to Achieve Highly Sought-After Self-Affirmed GRAS Status Designation LAS VEGAS, Sept. 10, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil, announced today that the Company’s hemp-derived CBD gold extract which includes all of PlusCBD Oil™ Gold Formula product line, … Continue reading CV Sciences, Inc. Achieves Industry’s First Hemp Extract GRAS Self-Affirmation →

LAS VEGAS, Aug. 08, 2018 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company,” “CV Sciences,” “our” or “we”) is pleased to announce the appointment of Joseph Maroon, MD, FACS (“Dr. Maroon”), to its Board of Directors. Dr. Maroon is a clinical professor and vice chairman of the Department of Neurological Surgery and the Heindl Scholar in … Continue reading World-Renowned Neurosurgeon, Health and Nutrition Expert, Dr. Joseph Maroon, Joins CV Sciences, Inc. Board of Directors →